

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 9.37467069 |
| 2 | lipoprotein transport (GO:0042953) | 8.25414117 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 8.09771329 |
| 4 | NADH metabolic process (GO:0006734) | 7.59347346 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 7.58230154 |
| 6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 7.45511841 |
| 7 | regulation of bile acid biosynthetic process (GO:0070857) | 6.92714001 |
| 8 | intestinal absorption (GO:0050892) | 6.63322397 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.43664019 |
| 10 | fructose metabolic process (GO:0006000) | 6.13776698 |
| 11 | hormone catabolic process (GO:0042447) | 5.98436895 |
| 12 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.76652449 |
| 13 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.76652449 |
| 14 | endocrine process (GO:0050886) | 5.76652449 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 5.57008939 |
| 16 | drug metabolic process (GO:0017144) | 5.42588503 |
| 17 | adhesion of symbiont to host cell (GO:0044650) | 5.41009213 |
| 18 | virion attachment to host cell (GO:0019062) | 5.41009213 |
| 19 | regulation of systemic arterial blood pressure (GO:0003073) | 5.15967841 |
| 20 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.02508933 |
| 21 | regulation of cGMP biosynthetic process (GO:0030826) | 4.92933850 |
| 22 | peptide hormone processing (GO:0016486) | 4.92234149 |
| 23 | cellular glucuronidation (GO:0052695) | 4.90930733 |
| 24 | glucuronate metabolic process (GO:0019585) | 4.82947959 |
| 25 | uronic acid metabolic process (GO:0006063) | 4.82947959 |
| 26 | diacylglycerol metabolic process (GO:0046339) | 4.77474112 |
| 27 | bile acid and bile salt transport (GO:0015721) | 4.77009767 |
| 28 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.65790090 |
| 29 | digestion (GO:0007586) | 4.62246951 |
| 30 | adhesion of symbiont to host (GO:0044406) | 4.60920936 |
| 31 | plasma lipoprotein particle assembly (GO:0034377) | 4.54176879 |
| 32 | peptide catabolic process (GO:0043171) | 4.52178310 |
| 33 | vitamin A metabolic process (GO:0006776) | 4.51795324 |
| 34 | urea cycle (GO:0000050) | 4.46763699 |
| 35 | regulation of cellular extravasation (GO:0002691) | 4.46627103 |
| 36 | renal system process involved in regulation of blood volume (GO:0001977) | 4.42147479 |
| 37 | cellular response to nitric oxide (GO:0071732) | 4.38458578 |
| 38 | glycolipid catabolic process (GO:0019377) | 4.38134934 |
| 39 | glycosphingolipid catabolic process (GO:0046479) | 4.31553970 |
| 40 | drinking behavior (GO:0042756) | 4.30464661 |
| 41 | urea metabolic process (GO:0019627) | 4.29211094 |
| 42 | fat-soluble vitamin metabolic process (GO:0006775) | 4.21915239 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.18503301 |
| 44 | flavonoid metabolic process (GO:0009812) | 4.15521000 |
| 45 | regulation of cGMP metabolic process (GO:0030823) | 4.13089280 |
| 46 | protein-lipid complex assembly (GO:0065005) | 4.11429905 |
| 47 | vitamin transmembrane transport (GO:0035461) | 4.09740526 |
| 48 | vitamin transport (GO:0051180) | 4.06793982 |
| 49 | regulation of vitamin metabolic process (GO:0030656) | 4.02737226 |
| 50 | alkaloid metabolic process (GO:0009820) | 4.01711337 |
| 51 | lipoprotein metabolic process (GO:0042157) | 4.00520660 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.95062009 |
| 53 | drug catabolic process (GO:0042737) | 3.89805805 |
| 54 | phospholipid efflux (GO:0033700) | 3.78200999 |
| 55 | cGMP biosynthetic process (GO:0006182) | 3.76440984 |
| 56 | vitamin biosynthetic process (GO:0009110) | 3.73887937 |
| 57 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.73821745 |
| 58 | exogenous drug catabolic process (GO:0042738) | 3.69710289 |
| 59 | regulation of cholesterol esterification (GO:0010872) | 3.68187074 |
| 60 | cellular response to reactive nitrogen species (GO:1902170) | 3.63411660 |
| 61 | vitamin D metabolic process (GO:0042359) | 3.62782883 |
| 62 | response to nitric oxide (GO:0071731) | 3.62449655 |
| 63 | mRNA modification (GO:0016556) | 3.60532602 |
| 64 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.56164391 |
| 65 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.55475026 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.55475026 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54644279 |
| 68 | bile acid metabolic process (GO:0008206) | 3.52108455 |
| 69 | cobalamin metabolic process (GO:0009235) | 3.51736192 |
| 70 | ceramide catabolic process (GO:0046514) | 3.48813344 |
| 71 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.45678778 |
| 72 | sphingomyelin metabolic process (GO:0006684) | 3.42778996 |
| 73 | glycosylceramide metabolic process (GO:0006677) | 3.41962881 |
| 74 | sulfate transmembrane transport (GO:1902358) | 3.39025697 |
| 75 | antibacterial humoral response (GO:0019731) | 3.38002811 |
| 76 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.35091853 |
| 77 | drug transport (GO:0015893) | 3.33635001 |
| 78 | glycerol metabolic process (GO:0006071) | 3.33156639 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.33024480 |
| 80 | sphingolipid catabolic process (GO:0030149) | 3.31680900 |
| 81 | midgut development (GO:0007494) | 3.30445194 |
| 82 | positive regulation of cGMP metabolic process (GO:0030825) | 3.28055471 |
| 83 | antimicrobial humoral response (GO:0019730) | 3.27948435 |
| 84 | heme transport (GO:0015886) | 3.26354510 |
| 85 | cytidine deamination (GO:0009972) | 3.25818456 |
| 86 | cytidine metabolic process (GO:0046087) | 3.25818456 |
| 87 | cytidine catabolic process (GO:0006216) | 3.25818456 |
| 88 | urate metabolic process (GO:0046415) | 3.25212343 |
| 89 | quinone biosynthetic process (GO:1901663) | 3.21473370 |
| 90 | L-ascorbic acid metabolic process (GO:0019852) | 3.21247120 |
| 91 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.20933343 |
| 92 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.19962440 |
| 93 | membrane lipid catabolic process (GO:0046466) | 3.19214211 |
| 94 | omega-hydroxylase P450 pathway (GO:0097267) | 3.17899757 |
| 95 | phenol-containing compound catabolic process (GO:0019336) | 3.16602072 |
| 96 | sulfur compound transport (GO:0072348) | 3.14775596 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.14589767 |
| 98 | drug transmembrane transport (GO:0006855) | 3.14245430 |
| 99 | digestive system process (GO:0022600) | 3.12694823 |
| 100 | angiotensin maturation (GO:0002003) | 12.3249774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.49560562 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.22929493 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.98231116 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.65352486 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25307637 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.06090490 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.98129148 |
| 8 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.94506117 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68235736 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56195910 |
| 11 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.55053529 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.49586976 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46670673 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.46262263 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.44293419 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42477863 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.31148653 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.22579162 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.05267125 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04027968 |
| 21 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.02772632 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80266108 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.74712546 |
| 24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.74216866 |
| 25 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.72734048 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70683244 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.66223823 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.66024066 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64097739 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62997557 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56158987 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.47906123 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47340971 |
| 34 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45981397 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42638655 |
| 36 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.33114511 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28837031 |
| 38 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27381621 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27112469 |
| 40 | GATA2_19941826_ChIP-Seq_K562_Human | 1.24576603 |
| 41 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.23761418 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21676924 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20781575 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16308247 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11935570 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10428915 |
| 47 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09197594 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07864424 |
| 49 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07588805 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07406931 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06369767 |
| 52 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04812633 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04545480 |
| 54 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04526316 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04497035 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03316328 |
| 57 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03051703 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02826575 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02116774 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02076249 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99500867 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99458038 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99011462 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96637842 |
| 65 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95388842 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94798883 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93986675 |
| 68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93925096 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93676116 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93100734 |
| 71 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92184865 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91719023 |
| 73 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.91532802 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90554375 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90252303 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90221783 |
| 77 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87988505 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87453231 |
| 79 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86892467 |
| 80 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.85996651 |
| 81 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84561148 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83792712 |
| 83 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.83789407 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83475245 |
| 85 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81015303 |
| 86 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79138163 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.78875464 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78151332 |
| 89 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77456906 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76933666 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76812974 |
| 92 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.76721075 |
| 93 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76529224 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76521903 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76159341 |
| 96 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75407455 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75362564 |
| 98 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74504356 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74308292 |
| 100 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.74229872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.90165291 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.03605850 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.00569341 |
| 4 | MP0003183_abnormal_peptide_metabolism | 4.92754054 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 4.00615811 |
| 6 | MP0004147_increased_porphyrin_level | 3.98163098 |
| 7 | MP0005365_abnormal_bile_salt | 3.96593109 |
| 8 | MP0009840_abnormal_foam_cell | 3.83116952 |
| 9 | MP0009379_abnormal_foot_pigmentation | 3.51558007 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 3.50185992 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 3.46776603 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.40933246 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.32199372 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.30719423 |
| 15 | MP0005409_darkened_coat_color | 2.11582235 |
| 16 | MP0005332_abnormal_amino_acid | 1.99235416 |
| 17 | MP0003868_abnormal_feces_composition | 1.98793188 |
| 18 | MP0001664_abnormal_digestion | 1.94066814 |
| 19 | MP0009643_abnormal_urine_homeostasis | 1.92066969 |
| 20 | MP0003866_abnormal_defecation | 1.74095303 |
| 21 | MP0000538_abnormal_urinary_bladder | 1.69478957 |
| 22 | MP0000490_abnormal_crypts_of | 1.67044342 |
| 23 | MP0005670_abnormal_white_adipose | 1.62718593 |
| 24 | MP0003252_abnormal_bile_duct | 1.59430862 |
| 25 | MP0001764_abnormal_homeostasis | 1.56950930 |
| 26 | MP0003718_maternal_effect | 1.50342699 |
| 27 | MP0001765_abnormal_ion_homeostasis | 1.47698245 |
| 28 | MP0001188_hyperpigmentation | 1.46411325 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.43254680 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.42201941 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.37393724 |
| 32 | MP0000678_abnormal_parathyroid_gland | 1.35020169 |
| 33 | MP0004270_analgesia | 1.28785169 |
| 34 | MP0000477_abnormal_intestine_morphology | 1.26269173 |
| 35 | MP0005166_decreased_susceptibility_to | 1.25111190 |
| 36 | MP0002136_abnormal_kidney_physiology | 1.24506515 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.23553155 |
| 38 | MP0003879_abnormal_hair_cell | 1.22738366 |
| 39 | MP0002822_catalepsy | 1.18737132 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.13953046 |
| 41 | MP0000462_abnormal_digestive_system | 1.11925373 |
| 42 | MP0005448_abnormal_energy_balance | 1.11843075 |
| 43 | MP0005535_abnormal_body_temperature | 1.08887885 |
| 44 | MP0002876_abnormal_thyroid_physiology | 0.99806973 |
| 45 | MP0000609_abnormal_liver_physiology | 0.99221893 |
| 46 | MP0002971_abnormal_brown_adipose | 0.99080945 |
| 47 | MP0002396_abnormal_hematopoietic_system | 0.98038529 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92618313 |
| 49 | MP0004043_abnormal_pH_regulation | 0.89199657 |
| 50 | MP0000230_abnormal_systemic_arterial | 0.88051518 |
| 51 | MP0001873_stomach_inflammation | 0.86309277 |
| 52 | MP0001663_abnormal_digestive_system | 0.85032617 |
| 53 | MP0001756_abnormal_urination | 0.82058710 |
| 54 | MP0009115_abnormal_fat_cell | 0.79692294 |
| 55 | MP0005451_abnormal_body_composition | 0.75549420 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 0.73448865 |
| 57 | MP0005381_digestive/alimentary_phenotyp | 0.73093717 |
| 58 | MP0009642_abnormal_blood_homeostasis | 0.72229259 |
| 59 | MP0001845_abnormal_inflammatory_respons | 0.72071774 |
| 60 | MP0002098_abnormal_vibrissa_morphology | 0.70710658 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 0.70583398 |
| 62 | MP0008469_abnormal_protein_level | 0.68240796 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67290373 |
| 64 | MP0004858_abnormal_nervous_system | 0.65729168 |
| 65 | MP0002796_impaired_skin_barrier | 0.65173048 |
| 66 | MP0000537_abnormal_urethra_morphology | 0.64143915 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.62763165 |
| 68 | MP0008872_abnormal_physiological_respon | 0.61554379 |
| 69 | MP0006138_congestive_heart_failure | 0.60337375 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.59662132 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.59316278 |
| 72 | MP0005334_abnormal_fat_pad | 0.58191105 |
| 73 | MP0005501_abnormal_skin_physiology | 0.56919207 |
| 74 | MP0005174_abnormal_tail_pigmentation | 0.56104628 |
| 75 | MP0009785_altered_susceptibility_to | 0.56005227 |
| 76 | MP0000249_abnormal_blood_vessel | 0.54108579 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 0.51979395 |
| 78 | MP0009764_decreased_sensitivity_to | 0.50623373 |
| 79 | MP0003953_abnormal_hormone_level | 0.50219278 |
| 80 | MP0008260_abnormal_autophagy | 0.49105255 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.48544475 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.46991204 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.45800859 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.42396072 |
| 85 | MP0009697_abnormal_copulation | 0.42132335 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.42059861 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.41763312 |
| 88 | MP0006082_CNS_inflammation | 0.40679807 |
| 89 | MP0002896_abnormal_bone_mineralization | 0.39730771 |
| 90 | MP0005395_other_phenotype | 0.39351018 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.38286089 |
| 92 | MP0001881_abnormal_mammary_gland | 0.37940388 |
| 93 | MP0003724_increased_susceptibility_to | 0.37258221 |
| 94 | MP0000604_amyloidosis | 0.35964654 |
| 95 | MP0000566_synostosis | 0.35793560 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.35628293 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.35156246 |
| 98 | MP0002135_abnormal_kidney_morphology | 0.34176632 |
| 99 | MP0005025_abnormal_response_to | 0.34072119 |
| 100 | MP0000516_abnormal_urinary_system | 0.34053861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of proline metabolism (HP:0010907) | 8.04715321 |
| 2 | Hydroxyprolinuria (HP:0003080) | 8.04715321 |
| 3 | Malnutrition (HP:0004395) | 7.30252304 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.46793609 |
| 5 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.93779475 |
| 6 | Chronic diarrhea (HP:0002028) | 5.62475213 |
| 7 | Abnormality of vitamin B metabolism (HP:0004340) | 5.56503054 |
| 8 | Acanthocytosis (HP:0001927) | 5.18432717 |
| 9 | Widely patent fontanelles and sutures (HP:0004492) | 5.18174596 |
| 10 | Confusion (HP:0001289) | 5.16871687 |
| 11 | Fat malabsorption (HP:0002630) | 5.05877189 |
| 12 | Ileus (HP:0002595) | 4.93115465 |
| 13 | Hyperglycinuria (HP:0003108) | 4.56385491 |
| 14 | Abnormality of vitamin metabolism (HP:0100508) | 4.38446048 |
| 15 | Pigmentary retinal degeneration (HP:0001146) | 4.10976835 |
| 16 | Nausea (HP:0002018) | 3.97048871 |
| 17 | Glycosuria (HP:0003076) | 3.87715229 |
| 18 | Abnormality of urine glucose concentration (HP:0011016) | 3.87715229 |
| 19 | Thin bony cortex (HP:0002753) | 3.85259018 |
| 20 | Wide cranial sutures (HP:0010537) | 3.80381540 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.79621667 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.79621667 |
| 23 | Proximal tubulopathy (HP:0000114) | 3.67046072 |
| 24 | Nephrolithiasis (HP:0000787) | 3.53628864 |
| 25 | Megaloblastic anemia (HP:0001889) | 3.47934360 |
| 26 | Steatorrhea (HP:0002570) | 3.33465169 |
| 27 | Xanthomatosis (HP:0000991) | 3.26701417 |
| 28 | Potter facies (HP:0002009) | 3.24869202 |
| 29 | Facial shape deformation (HP:0011334) | 3.24869202 |
| 30 | Increased purine levels (HP:0004368) | 3.24549262 |
| 31 | Hyperuricemia (HP:0002149) | 3.24549262 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.14890952 |
| 33 | Decreased circulating renin level (HP:0003351) | 3.14671539 |
| 34 | Abdominal distention (HP:0003270) | 3.11776207 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.09206384 |
| 36 | Posterior subcapsular cataract (HP:0007787) | 3.06888528 |
| 37 | Hypophosphatemia (HP:0002148) | 3.03587154 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.98790826 |
| 39 | Enlarged epiphyses (HP:0010580) | 2.95840629 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.94341270 |
| 41 | Abnormal urine phosphate concentration (HP:0012599) | 2.91603552 |
| 42 | Hyperactive renin-angiotensin system (HP:0000841) | 2.89728247 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.88844390 |
| 44 | Metabolic alkalosis (HP:0200114) | 2.88610288 |
| 45 | Alkalosis (HP:0001948) | 2.80064583 |
| 46 | Delayed epiphyseal ossification (HP:0002663) | 2.75752751 |
| 47 | Hyperammonemia (HP:0001987) | 2.67745768 |
| 48 | Hyperphosphaturia (HP:0003109) | 2.64623700 |
| 49 | Hyperparathyroidism (HP:0000843) | 2.61392123 |
| 50 | Abnormality of the costochondral junction (HP:0000919) | 2.60557100 |
| 51 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.54094068 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46136849 |
| 53 | Focal segmental glomerulosclerosis (HP:0000097) | 2.43718651 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.41540362 |
| 55 | Villous atrophy (HP:0011473) | 2.39180042 |
| 56 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.39180042 |
| 57 | Gout (HP:0001997) | 2.37691468 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.37552186 |
| 59 | Hypotension (HP:0002615) | 2.37268477 |
| 60 | Epidermoid cyst (HP:0200040) | 2.36714708 |
| 61 | Metabolic acidosis (HP:0001942) | 2.36294564 |
| 62 | Poikilocytosis (HP:0004447) | 2.31169523 |
| 63 | Subcapsular cataract (HP:0000523) | 2.25297528 |
| 64 | Abnormal glucose tolerance (HP:0001952) | 2.25053092 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24675159 |
| 66 | Protuberant abdomen (HP:0001538) | 2.21094017 |
| 67 | Eczematoid dermatitis (HP:0000976) | 2.18235988 |
| 68 | Abnormality of magnesium homeostasis (HP:0004921) | 2.10161064 |
| 69 | Renal tubular acidosis (HP:0001947) | 2.09154168 |
| 70 | Hyperphosphatemia (HP:0002905) | 2.03970645 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 11.2351153 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 1.99951654 |
| 73 | Renal tubular dysfunction (HP:0000124) | 1.99488246 |
| 74 | Irritability (HP:0000737) | 1.98127048 |
| 75 | Cerebral palsy (HP:0100021) | 1.95241945 |
| 76 | Gingivitis (HP:0000230) | 1.92048638 |
| 77 | Hemorrhage of the eye (HP:0011885) | 1.90909373 |
| 78 | Gastrointestinal dysmotility (HP:0002579) | 1.87719477 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86853917 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 1.86853917 |
| 81 | Pancreatitis (HP:0001733) | 1.85503353 |
| 82 | Multiple lipomas (HP:0001012) | 1.84089474 |
| 83 | White forelock (HP:0002211) | 1.83889526 |
| 84 | Patchy hypopigmentation of hair (HP:0011365) | 1.83401385 |
| 85 | Hypophosphatemic rickets (HP:0004912) | 1.79404040 |
| 86 | Symptomatic seizures (HP:0011145) | 1.77827398 |
| 87 | Glomerulosclerosis (HP:0000096) | 1.76189486 |
| 88 | Metaphyseal irregularity (HP:0003025) | 1.75689845 |
| 89 | Growth hormone excess (HP:0000845) | 1.75480838 |
| 90 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74996510 |
| 91 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74729677 |
| 92 | Abnormal albumin level (HP:0012116) | 1.71005583 |
| 93 | Hypoalbuminemia (HP:0003073) | 1.71005583 |
| 94 | Hypocalcemia (HP:0002901) | 1.70226768 |
| 95 | Lethargy (HP:0001254) | 1.66396565 |
| 96 | Dehydration (HP:0001944) | 1.65532521 |
| 97 | Paresthesia (HP:0003401) | 1.64225454 |
| 98 | Macrocytic anemia (HP:0001972) | 1.61446446 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.60267512 |
| 100 | Peripheral demyelination (HP:0011096) | 1.59185852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.65880630 |
| 2 | ERN1 | 4.18789164 |
| 3 | MST1R | 3.97544528 |
| 4 | PRKG2 | 3.74703490 |
| 5 | MAP3K10 | 3.55387662 |
| 6 | RIPK1 | 3.31903867 |
| 7 | EPHA2 | 2.55695101 |
| 8 | STK39 | 2.15844321 |
| 9 | TESK2 | 1.88402092 |
| 10 | MAP3K2 | 1.86095054 |
| 11 | OXSR1 | 1.78828161 |
| 12 | AKT3 | 1.78203352 |
| 13 | TNIK | 1.76066282 |
| 14 | PDK2 | 1.70919387 |
| 15 | MST4 | 1.70554644 |
| 16 | MAP3K12 | 1.60524508 |
| 17 | PTK6 | 1.56400348 |
| 18 | EPHA4 | 1.56382910 |
| 19 | GRK6 | 1.43768802 |
| 20 | MET | 1.43311119 |
| 21 | FGFR4 | 1.33251763 |
| 22 | EPHB2 | 1.29443565 |
| 23 | TYK2 | 1.28977779 |
| 24 | DDR2 | 1.25979956 |
| 25 | EPHA3 | 1.22012785 |
| 26 | STK24 | 1.11906169 |
| 27 | MATK | 1.06379011 |
| 28 | PIM1 | 1.06113887 |
| 29 | MAP2K2 | 1.02366844 |
| 30 | RIPK4 | 1.02327486 |
| 31 | MAP4K1 | 1.00279176 |
| 32 | EPHB1 | 0.98200751 |
| 33 | MYLK | 0.97784828 |
| 34 | MAP3K1 | 0.96165032 |
| 35 | CASK | 0.92542505 |
| 36 | PRPF4B | 0.91564826 |
| 37 | ERBB2 | 0.87017540 |
| 38 | NLK | 0.86336960 |
| 39 | PDPK1 | 0.82578676 |
| 40 | FGFR3 | 0.77252983 |
| 41 | PRKACG | 0.77143534 |
| 42 | DYRK1B | 0.73147671 |
| 43 | PRKAA2 | 0.72616304 |
| 44 | TESK1 | 0.71600384 |
| 45 | MAP2K6 | 0.71121403 |
| 46 | PIK3CA | 0.70631036 |
| 47 | MAP3K11 | 0.68957189 |
| 48 | BMPR2 | 0.67571121 |
| 49 | PRKCA | 0.63236708 |
| 50 | MAPK11 | 0.62702449 |
| 51 | PRKCZ | 0.62083414 |
| 52 | PDK1 | 0.61550327 |
| 53 | LMTK2 | 0.60997441 |
| 54 | TAOK1 | 0.60929942 |
| 55 | CDC42BPA | 0.57803965 |
| 56 | YES1 | 0.52241438 |
| 57 | FER | 0.51848740 |
| 58 | KSR2 | 0.51280951 |
| 59 | PRKCD | 0.45934159 |
| 60 | MAP3K3 | 0.45327024 |
| 61 | IRAK1 | 0.45230834 |
| 62 | ITK | 0.44896599 |
| 63 | SRC | 0.43444810 |
| 64 | CAMK2D | 0.43248521 |
| 65 | PIK3CG | 0.42179088 |
| 66 | FYN | 0.41334929 |
| 67 | NEK6 | 0.39951600 |
| 68 | PTK2 | 0.39689549 |
| 69 | DAPK2 | 0.39485798 |
| 70 | TEC | 0.38988425 |
| 71 | CAMK2G | 0.37766967 |
| 72 | TBK1 | 0.37713642 |
| 73 | RET | 0.35269691 |
| 74 | ABL2 | 0.34917305 |
| 75 | PAK4 | 0.34585302 |
| 76 | GRK1 | 0.33828232 |
| 77 | CAMK2B | 0.33760918 |
| 78 | CDK19 | 0.32086072 |
| 79 | BTK | 0.31476623 |
| 80 | CDK6 | 0.30969679 |
| 81 | MELK | 0.30414590 |
| 82 | JAK2 | 0.30309481 |
| 83 | CSF1R | 0.29594794 |
| 84 | PDGFRA | 0.29344536 |
| 85 | JAK1 | 0.28770366 |
| 86 | CSK | 0.25102166 |
| 87 | PRKACA | 0.24726347 |
| 88 | SYK | 0.24288735 |
| 89 | MAP3K8 | 0.23369535 |
| 90 | BMX | 0.20997939 |
| 91 | CAMK2A | 0.20200431 |
| 92 | PRKCI | 0.17123888 |
| 93 | IKBKE | 0.15659752 |
| 94 | LYN | 0.15511101 |
| 95 | IGF1R | 0.15339824 |
| 96 | ICK | 0.15257077 |
| 97 | RPS6KA2 | 0.14619853 |
| 98 | PRKCQ | 0.14552761 |
| 99 | EEF2K | 0.14047807 |
| 100 | PRKG1 | 0.13847972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 5.22930409 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.05046077 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.43526780 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.38629863 |
| 5 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.82453175 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.69812113 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.64875207 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.56886355 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52876941 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36855962 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.35359414 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.25302293 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 2.19423283 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.05855930 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02458153 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01982892 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01649576 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.01218038 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.97253457 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.95894363 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82530004 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81372657 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.71740465 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71643672 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.70219068 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55457820 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.46938119 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44440667 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42189047 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.37044163 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36964139 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.30324565 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26974527 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25167593 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22887261 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.16424212 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04240469 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01941740 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01620922 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96756186 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81992475 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80128820 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67322224 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64994056 |
| 45 | Asthma_Homo sapiens_hsa05310 | 0.63837137 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63711879 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63508339 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61056925 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51884126 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50669100 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50295103 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49252107 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45766937 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45496413 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 0.45027361 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.42899460 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39054123 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38440565 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.38388985 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 0.37275476 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.36352137 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.35685633 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34389537 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31148065 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25583416 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25386433 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.25342405 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.25284701 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23059250 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23027960 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20706623 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.20348568 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.20149180 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19820539 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19674250 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.18168719 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.17368948 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.16434586 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.16420125 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15958968 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.15851776 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15547725 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.11608671 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.07804709 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.07514579 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07508555 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07174953 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.04612895 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.03838398 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.03401343 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03348143 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00168640 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.00018000 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0249064 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | -0.0218946 |
| 96 | Gap junction_Homo sapiens_hsa04540 | -0.0199855 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | -0.0144446 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0051870 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | -0.0032694 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0018551 |

